142 related articles for article (PubMed ID: 19383797)
1. Fine mapping and functional analysis of a common variant in MSMB on chromosome 10q11.2 associated with prostate cancer susceptibility.
Lou H; Yeager M; Li H; Bosquet JG; Hayes RB; Orr N; Yu K; Hutchinson A; Jacobs KB; Kraft P; Wacholder S; Chatterjee N; Feigelson HS; Thun MJ; Diver WR; Albanes D; Virtamo J; Weinstein S; Ma J; Gaziano JM; Stampfer M; Schumacher FR; Giovannucci E; Cancel-Tassin G; Cussenot O; Valeri A; Andriole GL; Crawford ED; Anderson SK; Tucker M; Hoover RN; Fraumeni JF; Thomas G; Hunter DJ; Dean M; Chanock SJ
Proc Natl Acad Sci U S A; 2009 May; 106(19):7933-8. PubMed ID: 19383797
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancer risk SNP rs10993994 is a trans-eQTL for SNHG11 mediated through MSMB.
Bicak M; Wang X; Gao X; Xu X; Väänänen RM; Taimen P; Lilja H; Pettersson K; Klein RJ
Hum Mol Genet; 2020 Jun; 29(10):1581-1591. PubMed ID: 32065238
[TBL] [Abstract][Full Text] [Related]
3. MSMB variation and prostate cancer risk: clues towards a possible fungal etiology.
Sutcliffe S; De Marzo AM; Sfanos KS; Laurence M
Prostate; 2014 May; 74(6):569-78. PubMed ID: 24464504
[TBL] [Abstract][Full Text] [Related]
4. Promoter variants in the MSMB gene associated with prostate cancer regulate MSMB/NCOA4 fusion transcripts.
Lou H; Li H; Yeager M; Im K; Gold B; Schneider TD; Fraumeni JF; Chanock SJ; Anderson SK; Dean M
Hum Genet; 2012 Sep; 131(9):1453-1466. PubMed ID: 22661295
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer (PCa) risk variants and risk of fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
Shui IM; Lindström S; Kibel AS; Berndt SI; Campa D; Gerke T; Penney KL; Albanes D; Berg C; Bueno-de-Mesquita HB; Chanock S; Crawford ED; Diver WR; Gapstur SM; Gaziano JM; Giles GG; Henderson B; Hoover R; Johansson M; Le Marchand L; Ma J; Navarro C; Overvad K; Schumacher FR; Severi G; Siddiq A; Stampfer M; Stevens VL; Travis RC; Trichopoulos D; Vineis P; Mucci LA; Yeager M; Giovannucci E; Kraft P
Eur Urol; 2014 Jun; 65(6):1069-75. PubMed ID: 24411283
[TBL] [Abstract][Full Text] [Related]
6. A functional variant at a prostate cancer predisposition locus at 8q24 is associated with PVT1 expression.
Meyer KB; Maia AT; O'Reilly M; Ghoussaini M; Prathalingam R; Porter-Gill P; Ambs S; Prokunina-Olsson L; Carroll J; Ponder BA
PLoS Genet; 2011 Jul; 7(7):e1002165. PubMed ID: 21814516
[TBL] [Abstract][Full Text] [Related]
7. Fine-mapping the HOXB region detects common variants tagging a rare coding allele: evidence for synthetic association in prostate cancer.
Saunders EJ; Dadaev T; Leongamornlert DA; Jugurnauth-Little S; Tymrakiewicz M; Wiklund F; Al Olama AA; Benlloch S; Neal DE; Hamdy FC; Donovan JL; Giles GG; Severi G; Gronberg H; Aly M; Haiman CA; Schumacher F; Henderson BE; Lindstrom S; Kraft P; Hunter DJ; Gapstur S; Chanock S; Berndt SI; Albanes D; Andriole G; Schleutker J; Weischer M; Nordestgaard BG; Canzian F; Campa D; Riboli E; Key TJ; Travis RC; Ingles SA; John EM; Hayes RB; Pharoah P; Khaw KT; Stanford JL; Ostrander EA; Signorello LB; Thibodeau SN; Schaid D; Maier C; Kibel AS; Cybulski C; Cannon-Albright L; Brenner H; Park JY; Kaneva R; Batra J; Clements JA; Teixeira MR; Xu J; Mikropoulos C; Goh C; Govindasami K; Guy M; Wilkinson RA; Sawyer EJ; Morgan A; ; ; ; ; Easton DF; Muir K; Eeles RA; Kote-Jarai Z
PLoS Genet; 2014 Feb; 10(2):e1004129. PubMed ID: 24550738
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21.
Teerlink CC; Leongamornlert D; Dadaev T; Thomas A; Farnham J; Stephenson RA; Riska S; McDonnell SK; Schaid DJ; Catalona WJ; Zheng SL; Cooney KA; Ray AM; Zuhlke KA; Lange EM; Giles GG; Southey MC; Fitzgerald LM; Rinckleb A; Luedeke M; Maier C; Stanford JL; Ostrander EA; Kaikkonen EM; Sipeky C; Tammela T; Schleutker J; Wiley KE; Isaacs SD; Walsh PC; Isaacs WB; Xu J; Cancel-Tassin G; Cussenot O; Mandal D; Laurie C; Laurie C; ; ; Thibodeau SN; Eeles RA; Kote-Jarai Z; Cannon-Albright L
Hum Genet; 2016 Aug; 135(8):923-38. PubMed ID: 27262462
[TBL] [Abstract][Full Text] [Related]
9. Fine mapping of 14q24.1 breast cancer susceptibility locus.
Lee P; Fu YP; Figueroa JD; Prokunina-Olsson L; Gonzalez-Bosquet J; Kraft P; Wang Z; Jacobs KB; Yeager M; Horner MJ; Hankinson SE; Hutchinson A; Chatterjee N; Garcia-Closas M; Ziegler RG; Berg CD; Buys SS; McCarty CA; Feigelson HS; Thun MJ; Diver R; Prentice R; Jackson R; Kooperberg C; Chlebowski R; Lissowska J; Peplonska B; Brinton LA; Tucker M; Fraumeni JF; Hoover RN; Thomas G; Hunter DJ; Chanock SJ
Hum Genet; 2012 Mar; 131(3):479-90. PubMed ID: 21959381
[TBL] [Abstract][Full Text] [Related]
10. Identification of a new prostate cancer susceptibility locus on chromosome 8q24.
Yeager M; Chatterjee N; Ciampa J; Jacobs KB; Gonzalez-Bosquet J; Hayes RB; Kraft P; Wacholder S; Orr N; Berndt S; Yu K; Hutchinson A; Wang Z; Amundadottir L; Feigelson HS; Thun MJ; Diver WR; Albanes D; Virtamo J; Weinstein S; Schumacher FR; Cancel-Tassin G; Cussenot O; Valeri A; Andriole GL; Crawford ED; Haiman CA; Henderson B; Kolonel L; Le Marchand L; Siddiq A; Riboli E; Key TJ; Kaaks R; Isaacs W; Isaacs S; Wiley KE; Gronberg H; Wiklund F; Stattin P; Xu J; Zheng SL; Sun J; Vatten LJ; Hveem K; Kumle M; Tucker M; Gerhard DS; Hoover RN; Fraumeni JF; Hunter DJ; Thomas G; Chanock SJ
Nat Genet; 2009 Oct; 41(10):1055-7. PubMed ID: 19767755
[TBL] [Abstract][Full Text] [Related]
11. Fine-mapping the 2q37 and 17q11.2-q22 loci for novel genes and sequence variants associated with a genetic predisposition to prostate cancer.
Laitinen VH; Rantapero T; Fischer D; Vuorinen EM; Tammela TL; ; Wahlfors T; Schleutker J
Int J Cancer; 2015 May; 136(10):2316-27. PubMed ID: 25335771
[TBL] [Abstract][Full Text] [Related]
12. A comprehensive resequence-analysis of 250 kb region of 8q24.21 in men of African ancestry.
Chung CC; Hsing AW; Edward Yeboah ; Biritwum R; Tettey Y; Adjei A; Cook MB; De Marzo A; Netto G; Tay E; Boland JF; Yeager M; Chanock SJ
Prostate; 2014 May; 74(6):579-89. PubMed ID: 24783269
[TBL] [Abstract][Full Text] [Related]
13. Fine-mapping of prostate cancer aggressiveness loci on chromosome 7q22-35.
Liu X; Cheng I; Plummer SJ; Suarez BK; Casey G; Catalona WJ; Witte JS
Prostate; 2011 May; 71(7):682-9. PubMed ID: 20945404
[TBL] [Abstract][Full Text] [Related]
14. The role of plasma microseminoprotein-beta in prostate cancer: an observational nested case-control and Mendelian randomization study in the European prospective investigation into cancer and nutrition.
Smith Byrne K; Appleby PN; Key TJ; Holmes MV; Fensom GK; Agudo A; Ardanaz E; Boeing H; Bueno-de-Mesquita HB; Chirlaque MD; Kaaks R; Larrañaga N; Palli D; Perez-Cornago A; Quirós JR; Ricceri F; Sánchez MJ; Tagliabue G; Tsilidis KK; Tumino R; Fortner RT; Ferrari P; ; Riboli E; Lilja H; Travis RC
Ann Oncol; 2019 Jun; 30(6):983-989. PubMed ID: 31089709
[TBL] [Abstract][Full Text] [Related]
15. Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression.
Kote-Jarai Z; Saunders EJ; Leongamornlert DA; Tymrakiewicz M; Dadaev T; Jugurnauth-Little S; Ross-Adams H; Al Olama AA; Benlloch S; Halim S; Russell R; Dunning AM; Luccarini C; Dennis J; Neal DE; Hamdy FC; Donovan JL; Muir K; Giles GG; Severi G; Wiklund F; Gronberg H; Haiman CA; Schumacher F; Henderson BE; Le Marchand L; Lindstrom S; Kraft P; Hunter DJ; Gapstur S; Chanock S; Berndt SI; Albanes D; Andriole G; Schleutker J; Weischer M; Canzian F; Riboli E; Key TJ; Travis RC; Campa D; Ingles SA; John EM; Hayes RB; Pharoah P; Khaw KT; Stanford JL; Ostrander EA; Signorello LB; Thibodeau SN; Schaid D; Maier C; Vogel W; Kibel AS; Cybulski C; Lubinski J; Cannon-Albright L; Brenner H; Park JY; Kaneva R; Batra J; Spurdle A; Clements JA; Teixeira MR; Govindasami K; Guy M; Wilkinson RA; Sawyer EJ; Morgan A; Dicks E; Baynes C; Conroy D; Bojesen SE; Kaaks R; Vincent D; Bacot F; Tessier DC; ; ; ; ; Easton DF; Eeles RA
Hum Mol Genet; 2013 Jun; 22(12):2520-8. PubMed ID: 23535824
[TBL] [Abstract][Full Text] [Related]
16. The chromosome 2p21 region harbors a complex genetic architecture for association with risk for renal cell carcinoma.
Han SS; Yeager M; Moore LE; Wei MH; Pfeiffer R; Toure O; Purdue MP; Johansson M; Scelo G; Chung CC; Gaborieau V; Zaridze D; Schwartz K; Szeszenia-Dabrowska N; Davis F; Bencko V; Colt JS; Janout V; Matveev V; Foretova L; Mates D; Navratilova M; Boffetta P; Berg CD; Grubb RL; Stevens VL; Thun MJ; Diver WR; Gapstur SM; Albanes D; Weinstein SJ; Virtamo J; Burdett L; Brisuda A; McKay JD; Fraumeni JF; Chatterjee N; Rosenberg PS; Rothman N; Brennan P; Chow WH; Tucker MA; Chanock SJ; Toro JR
Hum Mol Genet; 2012 Mar; 21(5):1190-200. PubMed ID: 22113997
[TBL] [Abstract][Full Text] [Related]
17. Functional characterization of a chr13q22.1 pancreatic cancer risk locus reveals long-range interaction and allele-specific effects on DIS3 expression.
Hoskins JW; Ibrahim A; Emmanuel MA; Manmiller SM; Wu Y; O'Neill M; Jia J; Collins I; Zhang M; Thomas JV; Rost LM; Das S; Parikh H; Haake JM; Matters GL; Kurtz RC; Bamlet WR; Klein A; Stolzenberg-Solomon R; Wolpin BM; Yarden R; Wang Z; Smith J; Olson SH; Andresson T; Petersen GM; Amundadottir LT
Hum Mol Genet; 2016 Nov; 25(21):4726-4738. PubMed ID: 28172817
[TBL] [Abstract][Full Text] [Related]
18. HNF1B variants associate with promoter methylation and regulate gene networks activated in prostate and ovarian cancer.
Ross-Adams H; Ball S; Lawrenson K; Halim S; Russell R; Wells C; Strand SH; Ørntoft TF; Larson M; Armasu S; Massie CE; Asim M; Mortensen MM; Borre M; Woodfine K; Warren AY; Lamb AD; Kay J; Whitaker H; Ramos-Montoya A; Murrell A; Sørensen KD; Fridley BL; Goode EL; Gayther SA; Masters J; Neal DE; Mills IG
Oncotarget; 2016 Nov; 7(46):74734-74746. PubMed ID: 27732966
[TBL] [Abstract][Full Text] [Related]
19. Biology and Clinical Implications of the 19q13 Aggressive Prostate Cancer Susceptibility Locus.
Gao P; Xia JH; Sipeky C; Dong XM; Zhang Q; Yang Y; Zhang P; Cruz SP; Zhang K; Zhu J; Lee HM; Suleman S; Giannareas N; Liu S; ; Tammela TLJ; Auvinen A; Wang X; Huang Q; Wang L; Manninen A; Vaarala MH; Wang L; Schleutker J; Wei GH
Cell; 2018 Jul; 174(3):576-589.e18. PubMed ID: 30033361
[TBL] [Abstract][Full Text] [Related]
20. In silico functional pathway annotation of 86 established prostate cancer risk variants.
Loo LW; Fong AY; Cheng I; Le Marchand L
PLoS One; 2015; 10(2):e0117873. PubMed ID: 25658610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
